Accuray (NASDAQ:ARAY) Issues Earnings Results

Accuray (NASDAQ:ARAY) posted its quarterly earnings data on Thursday. The medical equipment provider reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.01, MarketWatch Earnings reports. Accuray had a net margin of 0.64% and a negative return on equity of 14.83%. During the same period last year, the firm earned ($0.02) earnings per share.

ARAY opened at $2.55 on Friday. The company has a quick ratio of 1.20, a current ratio of 1.95 and a debt-to-equity ratio of 3.62. Accuray has a 52-week low of $1.33 and a 52-week high of $4.68. The company has a 50 day moving average of $2.28 and a two-hundred day moving average of $2.38. The company has a market cap of $247.12 million, a P/E ratio of 127.56 and a beta of 2.04.

A number of research firms have recently weighed in on ARAY. Lake Street Capital reissued a “buy” rating and issued a $10.00 price objective on shares of Accuray in a research report on Sunday, June 21st. Cowen reissued an “average” rating and issued a $8.00 price objective on shares of Accuray in a research report on Sunday, June 21st. ValuEngine lowered shares of Accuray from a “buy” rating to a “hold” rating in a research report on Monday, August 3rd. Finally, BTIG Research reaffirmed a “buy” rating and set a $6.00 price target on shares of Accuray in a research report on Friday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $7.00.

About Accuray

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body.

Recommended Story: After-Hours Trading

Earnings History for Accuray (NASDAQ:ARAY)

Receive News & Ratings for Accuray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit